Symbols / APM $0.93 -2.93% Aptorum Group Limited

Healthcare • Biotechnology • United Kingdom • NCM
APM Chart
About

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 7.54M
Enterprise Value -1.85M Income -1.36M Sales —
Book/sh 2.84 Cash/sh 0.42 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -1.30 PEG —
P/S — P/B 0.33 P/C —
EV/EBITDA 1.18 EV/Sales — Quick Ratio 0.75
Current Ratio 0.78 Debt/Eq 25.05 LT Debt/Eq —
EPS (ttm) -0.19 EPS next Y -0.71 EPS Growth —
Revenue Growth — Earnings — ROA -6.52%
ROE -10.79% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 6.35M
Shs Float 4.46M Short Float 0.20% Short Ratio 0.36
Short Interest — 52W High 4.47 52W Low 0.65
Beta -0.01 Avg Volume 65.44K Volume 13.03K
Target Price — Recom None Prev Close $0.95
Price $0.93 Change -2.93%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.93
Latest analyst target
3. DCF / Fair value
$-3.11
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.93
Low
—
High
—
Mean
—
News
RSS: Latest APM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
0.43
-66.71%
1.30
Operating Revenue
0.00
0.00
-100.00%
0.43
-66.71%
1.30
Cost Of Revenue
0.00
0.00
-100.00%
0.42
-65.39%
1.22
Reconciled Cost Of Revenue
0.00
0.00
-100.00%
0.42
-65.39%
1.22
Gross Profit
0.00
0.00
-100.00%
0.01
-86.80%
0.08
Operating Expense
1.82
-39.46%
3.00
-71.71%
10.61
-38.50%
17.25
Research And Development
0.35
-83.92%
2.20
-57.77%
5.20
-43.62%
9.22
Selling General And Administration
1.64
+12.05%
1.46
-66.94%
4.41
-44.57%
7.97
Selling And Marketing Expense
—
0.00
-100.00%
0.05
-50.06%
0.10
General And Administrative Expense
1.64
+12.05%
1.46
-66.57%
4.37
-44.50%
7.87
Salaries And Wages
0.01
-96.08%
0.21
-76.68%
0.89
-76.45%
3.79
Other Gand A
1.29
+57.13%
0.82
-70.61%
2.78
-14.63%
3.26
Other Operating Expenses
-0.17
+73.96%
-0.66
-169.43%
0.94
+1368.68%
-0.07
Total Expenses
1.82
-39.46%
3.00
-72.79%
11.03
-40.27%
18.47
Operating Income
-1.82
+39.46%
-3.00
+71.68%
-10.60
+38.27%
-17.17
EBITDA
-1.82
+32.60%
-2.70
+70.76%
-9.22
+40.94%
-15.62
Normalized EBITDA
-2.35
-39.50%
-1.69
+89.16%
-15.57
+26.12%
-21.07
Reconciled Depreciation
0.00
-100.00%
0.31
-77.82%
1.38
-11.50%
1.56
EBIT
-1.82
+39.46%
-3.00
+71.68%
-10.60
+38.27%
-17.17
Total Unusual Items
0.54
+153.20%
-1.01
-115.90%
6.34
+16.33%
5.45
Total Unusual Items Excluding Goodwill
0.54
+153.20%
-1.01
-115.90%
6.34
+16.33%
5.45
Special Income Charges
0.00
+100.00%
-1.01
-1207.10%
-0.08
+85.18%
-0.52
Write Off
0.00
-100.00%
1.01
+1208.01%
0.08
-85.18%
0.52
Net Income
-1.36
+68.06%
-4.27
-51.09%
-2.82
+71.18%
-9.80
Pretax Income
-1.38
+66.89%
-4.16
+4.22%
-4.34
+62.33%
-11.53
Net Non Operating Interest Income Expense
-0.10
+34.86%
-0.15
-21.28%
-0.12
-182.64%
0.15
Interest Expense Non Operating
—
—
—
—
Net Interest Income
-0.10
+34.86%
-0.15
-21.28%
-0.12
-182.64%
0.15
Interest Expense
—
—
—
—
Interest Income Non Operating
—
—
—
0.15
Interest Income
—
—
—
0.15
Other Income Expense
0.54
+153.23%
-1.01
-115.80%
6.38
+15.98%
5.50
Other Non Operating Income Expenses
—
0.00
-98.47%
0.04
-23.38%
0.05
Gain On Sale Of Security
0.54
—
6.42
+7.48%
5.97
Gain On Sale Of Business
0.00
-100.00%
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-1.38
+66.89%
-4.16
+4.22%
-4.34
+62.33%
-11.53
Net Income From Continuing Operation Net Minority Interest
-1.36
+68.06%
-4.27
-51.09%
-2.82
+71.18%
-9.80
Net Income From Continuing And Discontinued Operation
-1.36
+68.06%
-4.27
-51.09%
-2.82
+71.18%
-9.80
Net Income Continuous Operations
-1.38
+66.89%
-4.16
+4.22%
-4.34
+62.33%
-11.53
Minority Interests
0.01
+111.96%
-0.11
-107.26%
1.52
-12.12%
1.73
Normalized Income
-1.90
+41.69%
-3.26
+64.46%
-9.17
+39.89%
-15.25
Net Income Common Stockholders
-1.36
+68.06%
-4.27
-51.09%
-2.82
+71.18%
-9.80
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
—
—
-0.62
+77.45%
-2.75
Basic EPS
—
—
-0.62
+77.45%
-2.75
Basic Average Shares
—
—
4.52
+26.66%
3.57
Diluted Average Shares
—
—
4.52
+26.66%
3.57
Diluted NI Availto Com Stockholders
-1.36
+68.06%
-4.27
-51.09%
-2.82
+71.18%
-9.80
Depreciation Amortization Depletion Income Statement
0.00
-100.00%
0.00
-93.53%
0.05
-62.51%
0.14
Depreciation And Amortization In Income Statement
0.00
-100.00%
0.00
-93.53%
0.05
-62.51%
0.14
Gain On Sale Of PPE
—
—
0.00
0.00
Insurance And Claims
0.22
-35.90%
0.34
-29.31%
0.47
-13.16%
0.55
Rent And Landing Fees
0.13
+29.90%
0.10
-54.49%
0.21
-19.53%
0.27
Rent Expense Supplemental
0.13
+29.90%
0.10
-54.49%
0.21
-19.53%
0.27
Total Other Finance Cost
0.10
-34.86%
0.15
+21.28%
0.12
+182.64%
-0.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
18.69
+15.88%
16.13
-21.85%
20.64
-1.09%
20.87
Current Assets
3.59
+274.40%
0.96
-61.25%
2.48
-64.97%
7.07
Cash Cash Equivalents And Short Term Investments
3.45
+294.96%
0.87
-56.40%
2.01
+1.02%
1.99
Cash And Cash Equivalents
3.45
+294.96%
0.87
-56.40%
2.01
+6.52%
1.88
Cash Financial
3.45
+294.96%
0.87
-56.40%
2.01
+6.52%
1.88
Other Short Term Investments
—
—
0.00
-100.00%
0.10
Receivables
0.00
-100.00%
0.00
-93.59%
0.07
-94.88%
1.39
Accounts Receivable
—
0.00
-100.00%
0.05
-72.65%
0.17
Other Receivables
—
0.00
-79.60%
0.02
-89.16%
0.21
Loans Receivable
—
—
0.00
-100.00%
0.88
Inventory
—
—
0.00
-100.00%
0.03
Prepaid Assets
0.14
+72.88%
0.08
-79.80%
0.40
-25.86%
0.54
Restricted Cash
—
—
0.00
-100.00%
3.13
Hedging Assets Current
—
—
—
—
Total Non Current Assets
15.10
-0.47%
15.17
-16.48%
18.16
+31.63%
13.80
Net PPE
0.00
0.00
-100.00%
1.85
-41.85%
3.17
Gross PPE
4.78
+0.00%
4.78
-13.53%
5.53
-28.56%
7.75
Accumulated Depreciation
-4.78
+0.00%
-4.78
-29.76%
-3.69
+19.32%
-4.57
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
0.00
-100.00%
0.18
-47.53%
0.35
Machinery Furniture Equipment
0.34
+0.00%
0.34
-27.57%
0.47
-24.41%
0.62
Construction In Progress
—
—
0.00
-100.00%
0.00
Other Properties
4.34
+0.00%
4.34
-0.02%
4.34
-30.38%
6.23
Leases
0.11
+0.00%
0.11
-80.11%
0.54
+0.00%
0.54
Goodwill And Other Intangible Assets
0.00
0.00
-100.00%
0.15
-80.42%
0.75
Other Intangible Assets
—
—
0.15
-80.42%
0.75
Investments And Advances
15.10
+0.00%
15.10
-6.21%
16.10
+65.20%
9.74
Non Current Prepaid Assets
0.00
-100.00%
0.07
+0.00%
0.07
-43.58%
0.13
Total Liabilities Net Minority Interest
4.90
+12.56%
4.35
-17.19%
5.26
-59.67%
13.03
Current Liabilities
4.59
+5.87%
4.34
+106.74%
2.10
-83.21%
12.50
Payables And Accrued Expenses
1.15
+15.29%
1.00
-49.42%
1.97
-68.06%
6.18
Payables
1.09
+11.14%
0.98
-49.69%
1.96
-67.69%
6.06
Other Payable
1.02
+12.17%
0.91
-51.81%
1.88
-68.94%
6.05
Current Accrued Expenses
0.06
+320.78%
0.01
-15.95%
0.02
-86.72%
0.12
Current Debt And Capital Lease Obligation
3.44
+3.06%
3.34
+2567.63%
0.13
-98.02%
6.32
Current Debt
3.42
+5.56%
3.24
—
6.01
Other Current Borrowings
3.42
+5.56%
3.24
—
3.01
Current Capital Lease Obligation
0.02
-76.10%
0.10
-18.37%
0.13
-59.67%
0.31
Total Non Current Liabilities Net Minority Interest
0.31
+2057.66%
0.01
-99.55%
3.16
+494.97%
0.53
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.01
-99.55%
3.16
+494.97%
0.53
Long Term Debt
—
—
3.06
+511.70%
0.50
Long Term Capital Lease Obligation
0.00
-100.00%
0.01
-85.74%
0.10
+223.17%
0.03
Stockholders Equity
23.16
+9.59%
21.13
-14.94%
24.85
+58.13%
15.71
Common Stock Equity
23.16
+9.59%
21.13
-14.94%
24.85
+58.13%
15.71
Capital Stock
0.00
+45.45%
0.00
+3.77%
0.00
-100.00%
35.71
Common Stock
0.00
+45.45%
0.00
+3.77%
0.00
-100.00%
35.71
Share Issued
8.14
+45.20%
5.61
+8.24%
5.18
+45.12%
3.57
Ordinary Shares Number
8.14
+45.20%
5.61
+8.24%
5.18
+45.12%
3.57
Additional Paid In Capital
97.00
+3.77%
93.47
+0.49%
93.02
+105.30%
45.31
Retained Earnings
-73.79
-1.88%
-72.43
-6.26%
-68.16
-4.32%
-65.34
Gains Losses Not Affecting Retained Earnings
-0.09
-203.53%
0.09
+939.33%
-0.01
-131.42%
0.03
Minority Interest
-9.37
-0.14%
-9.36
+1.11%
-9.46
-20.11%
-7.88
Other Equity Adjustments
-0.09
-203.53%
0.09
+939.33%
-0.01
-131.42%
0.03
Total Equity Gross Minority Interest
13.79
+17.11%
11.78
-23.44%
15.38
+96.38%
7.83
Total Capitalization
23.16
+9.59%
21.13
-24.26%
27.90
+72.12%
16.21
Working Capital
-1.00
+70.37%
-3.38
-995.59%
0.38
+106.94%
-5.44
Invested Capital
26.58
+9.06%
24.37
-12.66%
27.90
+25.55%
22.23
Total Debt
3.44
+2.62%
3.35
+2.18%
3.28
-52.10%
6.85
Net Debt
—
2.36
+124.49%
1.05
-77.26%
4.63
Capital Lease Obligations
0.02
-79.02%
0.12
-48.20%
0.22
-34.16%
0.34
Net Tangible Assets
23.16
+9.59%
21.13
-14.43%
24.70
+65.11%
14.96
Tangible Book Value
23.16
+9.59%
21.13
-14.43%
24.70
+65.11%
14.96
Derivative Product Liabilities
0.31
0.00
—
—
Duefrom Related Parties Current
—
0.00
-100.00%
0.00
-99.26%
0.13
Dueto Related Parties Current
0.08
-0.58%
0.08
+0.59%
0.08
+523.81%
0.01
Line Of Credit
—
—
0.00
-100.00%
3.00
Other Equity Interest
0.05
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-1.84
-54.37%
-1.19
+84.60%
-7.72
+37.30%
-12.32
Cash Flow From Continuing Operating Activities
-1.84
-54.37%
-1.19
+84.60%
-7.72
+37.30%
-12.32
Net Income From Continuing Operations
-1.38
+66.89%
-4.16
+4.22%
-4.34
+62.33%
-11.53
Depreciation Amortization Depletion
0.00
-100.00%
0.31
-77.82%
1.38
-11.50%
1.56
Depreciation
0.00
-100.00%
0.31
-77.82%
1.38
-11.50%
1.56
Amortization Cash Flow
—
—
0.08
-26.65%
0.11
Depreciation And Amortization
0.00
-100.00%
0.31
-77.82%
1.38
-11.50%
1.56
Amortization Of Intangibles
—
—
0.08
-26.65%
0.11
Other Non Cash Items
0.18
+0.00%
0.18
+111.24%
-1.60
-992.15%
-0.15
Stock Based Compensation
0.00
0.00
-100.00%
1.27
-23.18%
1.65
Provisionand Write Offof Assets
0.00
0.00
-100.00%
0.52
0.00
Asset Impairment Charge
0.00
-100.00%
2.75
+204.65%
0.90
+73.41%
0.52
Operating Gains Losses
-0.54
-804.88%
-0.06
-149.39%
0.12
-64.60%
0.34
Gain Loss On Investment Securities
-0.54
—
0.01
-93.09%
0.13
Unrealized Gain Loss On Investment Securities
0.00
0.00
+100.00%
-6.43
-5.27%
-6.11
Gain Loss On Sale Of PPE
—
—
0.11
-45.98%
0.21
Change In Working Capital
-0.10
+50.73%
-0.21
-145.42%
0.46
-66.98%
1.40
Change In Receivables
0.02
-94.75%
0.33
-20.09%
0.42
+342.70%
-0.17
Changes In Account Receivables
0.00
-100.00%
0.04
-67.37%
0.13
+232.41%
-0.10
Change In Inventory
0.00
0.00
-100.00%
0.01
+80.26%
0.01
Change In Prepaid Assets
0.00
0.00
-100.00%
0.03
+50.59%
0.02
Change In Payables And Accrued Expense
-0.03
+93.17%
-0.42
-208.24%
0.39
-79.60%
1.91
Change In Payable
-0.03
+93.17%
-0.42
-208.24%
0.39
-79.60%
1.91
Change In Account Payable
-0.03
+93.29%
-0.42
-206.04%
0.40
-79.22%
1.92
Change In Other Current Liabilities
-0.09
+23.87%
-0.12
+68.97%
-0.39
-5.37%
-0.37
Investing Cash Flow
0.00
-100.00%
0.06
-90.62%
0.62
-74.45%
2.44
Cash Flow From Continuing Investing Activities
0.00
-100.00%
0.06
-90.62%
0.62
-74.45%
2.44
Net PPE Purchase And Sale
0.00
-100.00%
0.06
+373.90%
0.01
+106.62%
-0.19
Purchase Of PPE
0.00
0.00
+100.00%
-0.00
+98.39%
-0.19
Sale Of PPE
0.00
-100.00%
0.06
+281.03%
0.02
0.00
Capital Expenditure
—
—
-0.00
+98.39%
-0.19
Net Investment Purchase And Sale
0.00
0.00
-100.00%
0.09
0.00
Sale Of Investment
0.00
0.00
-100.00%
0.09
0.00
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-0.00
0.00
0.00
Net Intangibles Purchase And Sale
—
—
0.00
0.00
Purchase Of Intangibles
—
—
0.00
0.00
Net Other Investing Changes
—
—
0.52
-80.27%
2.63
Financing Cash Flow
4.42
0.00
-100.00%
4.09
-38.24%
6.63
Cash Flow From Continuing Financing Activities
4.42
0.00
-100.00%
4.09
-38.24%
6.63
Net Issuance Payments Of Debt
0.00
0.00
-100.00%
2.50
-61.24%
6.45
Issuance Of Debt
0.00
0.00
-100.00%
5.50
-15.38%
6.50
Repayment Of Debt
0.00
0.00
+100.00%
-3.00
-5978.04%
-0.05
Long Term Debt Issuance
0.00
0.00
-100.00%
5.50
-15.38%
6.50
Long Term Debt Payments
0.00
0.00
+100.00%
-3.00
-5978.04%
-0.05
Net Long Term Debt Issuance
0.00
0.00
-100.00%
2.50
-61.24%
6.45
Short Term Debt Issuance
—
—
3.00
-50.00%
6.00
Short Term Debt Payments
—
—
-3.00
0.00
Net Short Term Debt Issuance
—
—
0.00
-100.00%
6.00
Net Common Stock Issuance
5.07
0.00
-100.00%
1.58
+29294.81%
0.01
Proceeds From Stock Option Exercised
0.00
0.00
-100.00%
0.02
-90.26%
0.17
Net Other Financing Charges
-0.65
—
—
—
Changes In Cash
2.58
+327.97%
-1.13
+62.39%
-3.01
+7.42%
-3.25
Beginning Cash Position
0.87
-56.40%
2.01
-60.00%
5.01
-39.32%
8.26
End Cash Position
3.45
+294.96%
0.87
-56.40%
2.01
-60.00%
5.01
Free Cash Flow
-1.84
-54.37%
-1.19
+84.60%
-7.73
+38.21%
-12.51
Interest Paid Supplemental Data
0.00
0.00
-100.00%
0.09
+45.35%
0.06
Income Tax Paid Supplemental Data
—
0.00
0.00
0.00
Common Stock Issuance
5.07
0.00
-100.00%
1.58
+29294.81%
0.01
Issuance Of Capital Stock
5.07
0.00
-100.00%
1.58
+29294.81%
0.01
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category